HRT Financial’s ResMed RMD Stock Holding History

HRT Financial’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$15.9M	Buy	70,938 +10,817	+18%	+$2.7M	0.04%	427
2025 Q4	$14.5M	Buy	60,121 +56,855	+1,741%	+$14.5M	0.05%	318
2025 Q3	$894K	Buy	+3,266	New	+$892K	﹤0.01%	1584
2024 Q3	–	Sell	-83,737	Closed	-$16M	–	3027
2024 Q2	$16M	Buy	83,737 +79,512	+1,882%	+$16.1M	0.09%	172
2024 Q1	$836K	Sell	4,225 -4,367	-51%	-$800K	0.01%	969
2023 Q4	$1.48M	Sell	8,592 -24,887	-74%	-$3.82M	0.01%	798
2023 Q3	$4.95M	Buy	33,479 +3,809	+13%	+$689K	0.05%	300
2023 Q2	$6.48M	Buy	+29,670	New	+$6.61M	0.06%	226
2023 Q1	–	Sell	-46,614	Closed	-$9.7M	–	3092
2022 Q4	$9.7M	Buy	+46,614	New	+$10.2M	0.14%	136
2022 Q3	–	Sell	-11,920	Closed	-$2.5M	–	3392
2022 Q2	$2.5M	Buy	+11,920	New	+$2.54M	0.03%	483
2022 Q1	–	Sell	-14,025	Closed	-$3.65M	–	3747
2021 Q4	$3.65M	Buy	+14,025	New	+$3.64M	0.02%	394
2021 Q2	–	Sell	-7,260	Closed	-$1.41M	–	3428
2021 Q1	$1.41M	Buy	+7,260	New	+$1.46M	0.01%	829
2020 Q2	–	Sell	-7,058	Closed	-$1.04M	–	1724
2020 Q1	$1.04M	Buy	+7,058	New	+$1.12M	0.07%	248

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

HRT Financial's RMD Position: Q1 2026 in Review

HRT Financial increased its ResMed (RMD) stake by 18% in Q1 2026, buying an estimated $2.7M and bringing the position to 70,938 shares worth $15.9M. The position accounts for 0.04% of the portfolio, ranked #427.

HRT Financial first reported a position in RMD in Q1 2020 and has held it in 13 quarters since. The position peaked at $16M in Q2 2024. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

HRT Financial held 70,938 shares of ResMed worth $15.9M as of Q1 2026.
HRT Financial bought 10,817 ResMed shares in Q1 2026, an estimated $2.7M.
ResMed made up 0.04% of HRT Financial's portfolio in Q1 2026, its #427 holding.
HRT Financial first reported a position in ResMed in Q1 2020 and has held it in 13 quarters since.
HRT Financial's ResMed position peaked at $16M in Q2 2024.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.